Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
HIMS - Hims & Hers Health, Inc.
Market Cap 1.75B P/E - EPS this Y 227.30% Ern Qtrly Grth -
Income -2.35M Forward P/E -139.67 EPS next Y 92.90% 50D Avg Chg -4.00%
Sales 959.4M PEG 0.88 EPS past 5Y - 200D Avg Chg 1.00%
Dividend N/A Price/Book 5.61 EPS next 5Y 113.50% 52W High Chg -32.00%
Recommedations 2.20 Quick Ratio 2.25 Shares Outstanding 206.41M 52W Low Chg 109.00%
Insider Own 11.53% ROA -0.79% Shares Float 185.96M Beta 0.96
Inst Own 63.64% ROE -0.72% Shares Shorted/Prior 18.39M/12.98M Price 8.38
Gross Margin 82.41% Profit Margin -0.25% Avg. Volume 3,115,700 Target Price 16.33
Oper. Margin 3.59% Earnings Date Aug 5 Volume 3,028,431 Change -4.34%
Consumer Defensive | Household & Personal Products | United States
About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc. News
05/16/24 Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
05/15/24 High Insider Ownership Growth Stocks On US Exchange For May 2024
05/09/24 Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
05/07/24 Oscar Health, Kenvue, Hims & Hers: Health earnings roundup
05/07/24 Telehealth Stock Gains Popularity With Options Bulls
05/06/24 Him & Hers Health stock soars on Q1 revenue beat, Q2 guidance
05/06/24 Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
04/16/24 Jefferies downgrades Hims & Hers Health on growth concerns
04/15/24 Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
04/04/24 Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
03/22/24 Nvidia's valuation forecasts aren't 'justified': Portfolio manager
03/11/24 Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
02/26/24 Hims & Hers Health, Unity Software: After-Hours Movers
02/26/24 Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
02/20/24 Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
02/05/24 Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
01/11/24 Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
12/04/23 Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
11/06/23 Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
11/06/23 Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
HIMS Chatroom

User Image RoSmoove Posted - 3 hours ago

$HIMS 10 BN market cap is first goal

User Image cannainvesting Posted - 22 hours ago

$HIMS great video once again, I'm glad I listened to this guy when HIMS went down because of the CEO tweet. BULLISH https://youtu.be/YRjf17TCBow

User Image Arsenalstockguy Posted - 1 day ago

@SocialYoutube you’re comparing fundamentals and market price. $hims at $150 would have a $30b mc. And yes, you can predict future moves lol

User Image Arsenalstockguy Posted - 1 day ago

$HIMS who’s to say Glp-1 can’t have this effect on hims?

User Image LucMach Posted - 1 day ago

@AGMholdings Teledoc reached $40BN MC before realizing that they weren't actually bringing in revenue from their services. Why shouldn't $HIMS do near that?

User Image KarlNietzsche Posted - 1 day ago

$HIMS no way to lose money here

User Image AGMholdings Posted - 1 day ago

$HIMS Being greedy while others were fearful is what allowed me to accumulate 13,704 shares at $5.29. Conviction is brought me here, conviction is making me stay until this is $10BN MC

User Image le_investor Posted - 1 day ago

@BuyNowUnlimited this is sick what CRISPr is doing, but once this gene therapy is approved, couldn't $hims just copy? Even if they are a year behind CRISPr

User Image RoSmoove Posted - 1 day ago

$HIMS 10 BN company easy, no doubt

User Image SocialYoutube Posted - 1 day ago

$HIMS Since The Telehealth Bubble 3 years ago: Doximity is the poster child for "Why Price Matters." It has a great business model, pristine balance sheet, unbelievable cash flow machine. But since inception has always been expensive relative to intrinsic value. Teladoc's ridiculously overpaid acquisition of Livongo has set them back so far. This company should be taken private, or spin off something and unload their debt into it. Lifestance, Talkspace, and LifeMD are all in the same "Can We Become Profitable" boat. Specifically with LifeMD, what percentage of their unearned revenue on the balance sheet has to be returned to customers for GLP-1 shortage reasons. Hims. The only telehealth company beating the S&P 500, and by 2X. Still at a fraction of their intrinsic value. Pristine balance sheet, biggest TAM, Only company devoting constant CAPEX to becoming the lowest-cost compound producer for chronic conditions I once saw Yemi kill a bear with a pencil.

User Image Jackie_O_ Posted - 1 day ago

$HIMS This will be in the mid 20's before anyone on Stocktwits will notice. Enjoy being early 👍😎

User Image Cristianoo Posted - 1 day ago

$HIMS I fucking love this company so much. This and Wingstop are my biggest holds , Weird combo but both aged well 😂

User Image Want2Invest42 Posted - 1 day ago

$HIMS damn it I was off a few days

User Image Loote17 Posted - 1 day ago

$HIMS

User Image liiontamer Posted - 1 day ago

$HIMS Reminder for the z-boy weenie babies. Seethe.

User Image BuyNowUnlimited Posted - 1 day ago

$HIMS interesting

User Image slem7 Posted - 1 day ago

$HIMS MACD cross on the weekly chart on deck for next week. Expecting the bid-ask will follow through. Momentum is your friend.

User Image OptionsGalore Posted - 1 day ago

$HIMS what a run up after terrorist sympathizers tried to tank this.

User Image rusucrypto1 Posted - 1 day ago

$HIMS even own the stock? If do, what’s your avg? 🤔

User Image Moneyidea8 Posted - 1 day ago

$HIMS Good to own few hundred shares. In the long run, CRISPR tech shall kill HIMS moat. Checkout CRISPr companies pipelines. Also CRISPR tech based hairloss solution is in pretrials. Look it up. HIMS revenue shall go up for few years but will be on downfall by around 2030

User Image Jackie_O_ Posted - 1 day ago

$HIMS Up nearly 18% on the week. Great start. 👍😎

User Image happyhouractual Posted - 1 day ago

$HIMS its because people just loooove to pay higher cost for fluffy mktg! Those commercials are hysterical-people sound so dumb.

User Image Arsenalstockguy Posted - 1 day ago

@FlynancialAnalyst keep an eye out on $VIRT as a sympathy play. And $HIMS as another big one to watch my man. Love the posts.

User Image Arsenalstockguy Posted - 1 day ago

$HIMS wait til the volume picks up 😏

User Image happyhouractual Posted - 1 day ago

$HIMS Blind or zero research-which one?

User Image Inveztmtl Posted - 1 day ago

$HIMS where the complainers ? I love this ceo makes me mloney

User Image 70mustang Posted - 1 day ago

$HIMS good day for a Friday, people taking profits..understandable...next week next leg up. Maybe 16-18? Any news and it melts faces off

User Image Inveztmtl Posted - 1 day ago

$HIMS who sold since april 12 ?

User Image BirdyBird Posted - 1 day ago

$HIMS this bad boy is headed to the moon 🚀 get on board or get left behind

User Image liiontamer Posted - 1 day ago

$HIMS woah.

Analyst Ratings
Deutsche Bank Hold May 7, 24
Piper Sandler Neutral May 7, 24
Jefferies Hold Apr 16, 24
Canaccord Genuity Buy Apr 10, 24
Guggenheim Buy Feb 27, 24
Citigroup Buy Feb 27, 24
Piper Sandler Neutral Feb 27, 24
Truist Securities Hold Feb 27, 24
Leerink Partners Market Perform Feb 26, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jan 25 Sell 9.06 195,728 1,773,296 51,653 01/29/24
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jan 25 Option 2.43 195,728 475,619 66,753 01/29/24
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Dec 27 Sell 9.03 54,882 495,584 51,653 12/29/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Dec 27 Option 2.43 54,882 133,363 73,085 12/29/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Nov 30 Sell 9.02 28,100 253,462 12/15/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Nov 30 Option 2.43 28,100 68,283 24,300 12/15/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Dec 04 Sell 8.87 27,399 243,029 382,574 12/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Dec 04 Option 0.4 3,624 1,450 407,473 12/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Nov 06 Sell 6.83 27,399 187,135 403,849 11/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Nov 06 Option 0.4 27,399 10,960 412,982 11/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Oct 05 Sell 6.2309 9,133 56,907 403,849 10/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Oct 03 Sell 6.25 18,266 114,162 412,982 10/06/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Sep 20 Sell 6.27 15,504 97,210 168,089 09/22/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Sep 20 Sell 6.28 6,794 42,666 150,982 09/22/23
O'Keefe Lynne Chou Director Director Sep 19 Sell 6.31 10,045 63,384 09/20/23
Becklund Irene PAO PAO Sep 19 Sell 6.31 10,596 66,861 5,494 09/20/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Sep 01 Sell 6.85 27,399 187,683 399,352 09/06/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Aug 21 Sell 6.9154 6,698 46,319 125,016 08/22/23
O'Keefe Lynne Chou Director Director Aug 09 Sell 7.15 45,748 327,098 08/16/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Aug 08 Sell 9.04 6,900 62,376 08/09/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Aug 08 Option 2.43 6,900 16,767 6,900 08/09/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 06 Sell 8.68 9,133 79,274 454,150 07/10/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 06 Option 0.4 9,133 3,653 463,283 07/10/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 03 Sell 9.03 18,266 164,942 454,150 07/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 03 Option 0.4 18,266 7,306 463,283 07/06/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 06 Sell 9.13 71,933 656,748 385,947 06/08/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 06 Option 2.43 73,942 179,679 457,880 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jun 06 Sell 9.1 18,266 166,221 422,260 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jun 06 Option 0.4 11,614 4,646 431,393 06/08/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 02 Sell 9.0359 2,009 18,153 383,938 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 09 Sell 10.78 12,966 139,773 422,579 05/11/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 09 Option 0.4 25,932 10,373 435,545 05/11/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 05 Sell 11.93 31,998 381,736 403,547 05/09/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 05 Option 0.4 19,032 7,613 422,579 05/09/23
Becklund Irene PAO PAO Apr 04 Sell 10.3 15,890 163,667 04/06/23
Becklund Irene PAO PAO Apr 04 Option 1.75 567 992 567 04/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Apr 04 Sell 10 30,065 300,650 445,778 04/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Mar 20 Sell 9.542 9,333 89,055 475,843 03/21/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Mar 16 Sell 9.91 22,119 219,199 485,176 03/20/23
Becklund Irene PAO PAO Mar 17 Sell 9.79 6,170 60,404 15,323 03/20/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Mar 17 Sell 9.9 15,720 155,628 99,013 03/20/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Mar 17 Sell 9.79 13,745 134,564 168,089 03/20/23
Maltz Jules A. 10% Owner 10% Owner Mar 02 Sell 10.1 36,820 371,882 03/06/23
Bard Alex Director Director Mar 01 Sell 11.17 2,819,109 31,489,448 7,349,710 03/03/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Jan 17 Sell 7.51 2,000 15,020 287,089 01/19/23
O'Keefe Lynne Chou Director Director Sep 20 Sell 5.68 10,046 57,061 09/21/22
Becklund Irene PAO PAO Sep 20 Sell 5.68 10,668 60,594 6,978 09/21/22
Becklund Irene PAO PAO Jul 05 Sell 5 19,331 96,655 13,717 07/06/22
O'Keefe Lynne Chou Director Director Jun 21 Sell 4.35 10,045 43,696 06/22/22
Maltz Jules A. Director Director Jun 14 Buy 3.66 75,000 274,500 125,000 06/16/22